# Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

Study · id `cardio:ct-nct05007925` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05007925](<https://clinicaltrials.gov/study/NCT05007925>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05007925

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.

## Technical summary

Registry record NCT05007925. Allocation not applicable; no masking; primary purpose treatment. Start 2021-11-18 (actual); primary completion 2024-03-25 (actual). Results posted on 2025-08-05.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 250 participants (enrolled count; ClinicalTrials.gov record NCT05007925, source copy `cardio:ctgov-nct05007925-2026-05-05`, retrieved 2026-10-31)
- Started: 2021-11-18 (actual) (ClinicalTrials.gov record NCT05007925, source copy `cardio:ctgov-nct05007925-2026-05-05`, retrieved 2026-10-31)
- Primary completion: 2024-03-25 (actual) (ClinicalTrials.gov record NCT05007925, source copy `cardio:ctgov-nct05007925-2026-05-05`, retrieved 2026-10-31)
- Completion: 2026-03-27 (actual) (ClinicalTrials.gov record NCT05007925, source copy `cardio:ctgov-nct05007925-2026-05-05`, retrieved 2026-10-31)
- Results first posted: 2025-08-05 (ClinicalTrials.gov record NCT05007925, source copy `cardio:ctgov-nct05007925-2026-05-05`, retrieved 2026-10-31)
- Countries: United States; Germany (ClinicalTrials.gov record NCT05007925, source copy `cardio:ctgov-nct05007925-2026-05-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05007925-2026-05-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
- Condition: Peripheral Artery Disease
- Intervention (Device): Intravascular Lithotripsy
- Lead sponsor: Shockwave Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Shockwave Medical, Inc. (`cardio:org-shockwave-medical-inc`)

## Provenance

Content hash: 6d2eabaa591c0c16ece892666c964a8625a4903229ef55def282dbe190c5e01e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
